Drug search by name

Recombivax HB Pediatric/Adolescent and Hemophilia

Result of checking the interaction of drug Recombivax HB Pediatric/Adolescent and disease Hemophilia for safety when used together.

Check result:

Recombivax HB Pediatric/Adolescent <> Hemophilia

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Hepatitis B vaccine (adult and pediatric) is usually for intramuscular administration. However, it may be administered subcutaneously to persons at risk for hemorrhage following intramuscular injections (e.g., hemophiliacs), although it may result in lower antibody response. Additionally, when other aluminum- absorbed vaccines have been administered subcutaneously, an increased incidence of local reactions including subcutaneous nodules has been observed. Therefore, consider subcutaneous administration only in persons who are at risk of hemorrhage following intramuscular injections.

Recombivax HB Pediatric/Adolescent

Generic Name: hepatitis b pediatric vaccine

Brand Name: Engerix-B Pediatric, Recombivax HB Pediatric/Adolescent, Recombivax HB

Synonyms: n.a.

What is Recombivax HB Pediatric/Adolescent?